Sunitinib

Details

Files

Generic Name:

Sunitinib

Project Status:

Complete

Therapeutic Area:

Gastrointestinal stromal tumour (GIST)

Manufacturer:

Pfizer Canada Inc.

Brand Name:

Sutent

Project Line:

Reimbursement Review

Project Number:

SR0069-000

Submission Type:

Initial

Indications:

Gastrointestinal stromal tumour (GIST)

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

March 28, 2007

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : July 20, 2006